Target intelligence / Profile preview

Myozenin-2 (MYOZ2)

Target
MYOZ2
Molecular classification
Other (sarcomeric structural protein), Cytoskeletal protein
01

Overview

Myozenin-2 (MYOZ2) is a muscle-specific sarcomeric protein localized at the Z-disc of cardiac and slow-twitch skeletal muscle fibers. It serves as an anchor for calcineurin, a calcium/calmodulin-dependent phosphatase, tethering it to alpha-actinin and other structural components at the sarcomere. By inhibiting calcineurin signaling, MYOZ2 suppresses pathological cardiac hypertrophy and regulates muscle fiber type specification and development. Mutations in MYOZ2 cause familial hypertrophic cardiomyopathy type 16 and have been implicated in broader muscle and heart pathologies. No drugs are known to directly target MYOZ2, but its function affects the progression and drug response in heart disease. MYOZ2 is not classified as a receptor, enzyme, transporter, or ion channel, but rather as a structural and signaling modulator in muscle tissue.

Other names
Calsarcin-1C4orf5CMH16CS-1FATZ-2FATZ-related protein 2Calcineurin-binding protein calsarcin-1Muscle-specific protein
02

Biological functions

Modulation of calcineurin signalingStructural maintenance of sarcomere Z-discInhibition of pathological cardiac hypertrophyMuscle development (myofibrillogenesis)
03

Disease associations

Cardiovascular disease (Familial hypertrophic cardiomyopathy, Dilated cardiomyopathy)Muscular dystrophy (suggested associations)Cancer (expression changes noted in gastric cancer)
04

Biomarkers

MYOZ2 mutations or expression levels may serve as biomarkers in familial hypertrophic cardiomyopathy and possibly as prognostic indicators in certain cancers

Beyond the preview

Go deeper on Myozenin-2 (MYOZ2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myozenin-2 (MYOZ2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call